June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Ocular Examinations for Uveitis in S1 Sinclair Swine in Response to HSP70iQ435A
Author Affiliations & Notes
  • Benjamin Reiss
    Ophthalmology, John H Stroger, Jr Hospital of Cook County, Chicago, Illinois, United States
  • Shannon Hunt
    Loyola University Medical Center, Chicago, Illinois, United States
  • Steven Henning
    Loyola University Medical Center, Chicago, Illinois, United States
  • Charles S Bouchard
    Loyola University Medical Center, Chicago, Illinois, United States
  • Caroline Le Poole
    Loyola University Medical Center, Chicago, Illinois, United States
  • Veena Rao Raiji
    Ophthalmology, John H Stroger, Jr Hospital of Cook County, Chicago, Illinois, United States
  • Footnotes
    Commercial Relationships   Benjamin Reiss, None; Shannon Hunt, None; Steven Henning, None; Charles Bouchard, None; Caroline Le Poole, patent application 14/127,579 (I); Veena Raiji, None
  • Footnotes
    Support  RO1 Separating Tumor Immunity and Autoimmunity
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 2173. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Benjamin Reiss, Shannon Hunt, Steven Henning, Charles S Bouchard, Caroline Le Poole, Veena Rao Raiji; Ocular Examinations for Uveitis in S1 Sinclair Swine in Response to HSP70iQ435A. Invest. Ophthalmol. Vis. Sci. 2017;58(8):2173.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : A subset of S1 Sinclair swine who develop cutaneous melanoma and spontaneous tumor regression may develop depigmentation of the skin, hair, and eyes (thought to be due to T cell mediated destruction of melanocytes) and uveal inflammation (due to immunologic cross reaction). Heat shock protein 70 (HSP70i) plays an important role in vitiligo development, and an HSP70iQ435A construct has been shown to support repigmentation. Ocular examinations were conducted to detect any pigmentary or inflammatory changes that may occur during observation or treatment of vitiligo lesions.

Methods : The treatment group (n=3) underwent jet injection of HSP70iQ435A encoding DNA into vitiligo lesions weekly for 4 weeks, and vitiligo lesions in the control group (n=3) were injected with phosphate-buffered saline. Ocular exams, blood draws (to monitor anti-HSP70i titers), and peri-lesional skin biopsies were conducted under isoflurane anesthesia. Examinations were performed at 4-week intervals during each swine’s 26-week observation cycle and included videos of each eye and external, anterior segment, and funduscopic examinations. The observing ophthalmologist was blinded to the swine’s treatment randomization but was aware of which swine was being examined.

Results : The presence of conjunctival plaques (2 controls), dilated iris vessels (2 treatment, 1 control), and hypopigmented retinal lesions (2 treatment) were deemed normal variants. A round, bluish lesion (choroidal nevus) was noted in the retina of one swine (treatment). One swine (control) exhibited dilated conjunctival vessels on initial examination that significantly increased in size at the 24-week examination and then stabilized. Another swine (treatment) developed multiple nummular perivascular areas of retinal hypopigmentation in both eyes at the 4-week examination (6 examinations remaining). A significant reduction in cutaneous depigmentation was observed in HSP70iQ435A -treated lesions: +2.8 cm2 in untreated lesions compared to -6.2 cm2 in DNA treated lesions at 26 weeks.

Conclusions : HSP70iQ435A–treated vitiligo lesions in S1 Sinclair swine showed cutaneous repigmentation without ocular inflammatory side effects or changes in tumor growth, suggesting that HSP70iQ435A may suppress autoimmunity without impacting anti-tumor responses. Numerous ocular normal variants were observed, and the significance of nummular perivascular hypopigmentation remains to be elucidated.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×